Jie Cheng
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 10
- Cancer, Hypoxia, and Metabolism 8
- Molecular Biology top 5%
- RNA modifications and cancer 16
- Epigenetics and DNA Methylation 15
- Cancer-related gene regulation 10
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Otorhinolaryngology top 5%
- Genetics top 5%
-
- Autophagy in Disease and Therapy 10
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (3 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jie Cheng
153 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1000
- Molecular Biology 2.1k
- Oncology 785
- Otorhinolaryngology 116
- Genetics 232
Countries citing papers authored by Jie Cheng
This map shows the geographic impact of Jie Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Cheng more than expected).
Fields of papers citing papers by Jie Cheng
This network shows the impact of papers produced by Jie Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Cheng. The network helps show where Jie Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 0 | |
| 9 | 2021 | 22 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 26 | |
| 12 | 2021 | 12 | |
| 13 | 2020 | 98 | |
| 14 | 2019 | 18 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 29 | |
| 17 | 2016 | 28 | |
| 18 | 2013 | 11 | |
| 19 | 2013 | 3 | |
| 20 | Fabrication of TiO_2@C Core-shell Nanofiber Arrays Electrode and Its Appdication in Electrochemical Sensing | 2008 | 1 |
About Jie Cheng
Jie Cheng is a scholar working on Complementary and Manual Therapy, Cancer Research and Oncology, having authored 163 papers that have together received 3.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (16 papers), Epigenetics and DNA Methylation (15 papers), MicroRNA in disease regulation (10 papers), Cancer-related gene regulation (10 papers), Autophagy in Disease and Therapy (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Cancer Research (1000 citations), Molecular Biology (2.1k citations) and Oncology (785 citations). Jie Cheng has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hongbing Jiang, Yanling Wang, Yu Fu, Dongmiao Wang, Rongyao Xu, Jinhai Ye, Ziqi Tian, Yan He, Jibo Dou and Jianming Xu. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.